Hengrui Pharma Reports RMB24.41 Billion Nine-Month Revenue
Hengrui Pharma reported revenue of RMB24.41 billion for the first nine months of 2026, up 5.26% year over year.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Hengrui Pharma reported revenue of RMB24.41 billion for the first nine months of 2026, up 5.26% year over year.